Product life cycle
We help adapt the access and commercialization strategy throughout the product life cycle.
#pricing strategy, #intellectual protection, #generics, biosimilars, #therapeutic equivalents, #partnerships

Philippe Géhin
Expert in the health sector in Public Affairs and Economic Affairs.

Robert Dahan
Double medical and commercial expertise to serve innovation and to optimize use of medicines.

Véronique Ameye
More than 40 years of operational experience in health products, from market access to marketing and public affairs.